Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen Inc. | -0.24% | 343.28 | 1.2% | $589.37m | |
| GILD | Gilead Sciences, Inc. | 1.33% | 73.32 | 0.9% | $534.10m | |
| CELG | Celgene Corporation | 0.35% | 91.20 | 1.2% | $502.04m | |
| AMGN | Amgen Inc. | -0.13% | 197.31 | 1.2% | $470.98m | |
| ILMN | Illumina, Inc. | 1.67% | 331.44 | 3.5% | $390.25m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.00% | 378.56 | 2.6% | $309.76m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.65% | 176.86 | 1.9% | $202.70m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.71% | 116.99 | 2.0% | $186.49m | |
| A | Agilent Technologies, Inc. | 0.75% | 64.95 | 1.5% | $163.20m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.18% | 129.14 | 16.6% | $139.77m | |
| NKTR | Nektar Therapeutics | 2.24% | 61.96 | 5.6% | $128.47m | |
| EXAS | Exact Sciences Corporation | 1.71% | 50.05 | 25.3% | $122.85m | |
| BLUE | Bluebird Bio, Inc. | 0.06% | 158.80 | 14.6% | $120.19m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.72% | 99.74 | 4.4% | $119.07m | |
| INCY | Incyte Corporation | 0.83% | 69.62 | 2.5% | $116.18m |
Company Profile
Pluristem Therapeutics, Inc. is a biotechnology company, which engages in the provision of cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The company focuses on cell therapies for the treatment of diseases such as muscle injury, acute radiation syndrome, pulmonary arterial hypertension and others. Its products include PLacental eXpanded, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.